NEW YORK, March 2 - Former Millennium Pharmaceuticals chief technology officer Frank Lee has joined EngeneOS, a start-up biomolecular engineering company based in Cambridge, Mass.

Lee will become president and CEO of EngeneOS (pronounced ingenious), which counts Eric Lander as a member of its scientific advisory board. The company hopes to develop molecular machines using a combination of genomics, biotechnology, and the physical sciences, Lee said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.